Tissue Regenix Group Plc (TRX) — Tangible Net Worth Ratio

Latest as of June 2025: 43.0%

Tissue Regenix Group Plc (TRX) has a Tangible Net Worth Ratio of 43.0% as of June 2025. This metric is calculated by deducting intangible assets (GBX16.31 Million) from net assets (GBX28.62 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how liquid is Tissue Regenix Group Plc's working capital to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

43.0%
Tangible equity / total equity

Net Assets (Equity)

GBX28.62 Million
GBX

Intangible Assets

GBX16.31 Million
Goodwill, patents, brand value

Total Assets

GBX47.19 Million
GBX

Tissue Regenix Group Plc Tangible Net Worth Ratio (2007–2024)

This chart shows how Tissue Regenix Group Plc's Tangible Net Worth Ratio has changed across 20 annual periods from 2007 to 2024. As of June 2025, the ratio stands at 43.0%, reflecting net assets of GBX28.62 Million with intangible assets of GBX16.31 Million GBX. See defensive interval ratio of Tissue Regenix Group Plc to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Tissue Regenix Group Plc (2007–2024)

The table below presents the year-by-year Tangible Net Worth Ratio for Tissue Regenix Group Plc from 2007 to 2024, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Tissue Regenix Group Plc.

Year Tangible NW Ratio Net Assets (GBX) Intangible Assets Total Assets Change (pp)
2024 85.6% GBX29.06 Million GBX4.18 Million GBX45.35 Million ▼ -8.9 pp
2023 94.5% GBX29.36 Million GBX1.62 Million GBX43.24 Million ▲ +44.0 pp
2022 50.5% GBX25.27 Million GBX12.52 Million GBX38.27 Million ▼ -4.4 pp
2021 54.9% GBX24.65 Million GBX11.12 Million GBX34.13 Million ▼ -5.9 pp
2020 60.7% GBX27.85 Million GBX10.93 Million GBX36.73 Million ▲ +33.9 pp
2019 26.8% GBX24.59 Million GBX18.00 Million GBX30.50 Million ▼ -12.0 pp
2018 38.8% GBX32.57 Million GBX19.94 Million GBX37.66 Million ▼ -49.1 pp
2018 87.9% GBX39.52 Million GBX4.80 Million GBX45.76 Million ▲ +36.7 pp
2017 51.2% GBX39.52 Million GBX19.30 Million GBX45.76 Million ▼ -44.1 pp
2016 95.2% GBX11.54 Million GBX550.00K GBX13.60 Million ▼ -4.8 pp
2016 100.0% GBX30.25 Million GBX0.00 GBX33.04 Million ▲ +0.0 pp
2015 100.0% GBX11.58 Million GBX0.00 GBX12.67 Million ▲ +0.0 pp
2014 100.0% GBX31.30 Million GBX0.00 GBX33.13 Million ▲ +0.0 pp
2013 100.0% GBX38.64 Million GBX0.00 GBX39.73 Million ▲ +0.0 pp
2012 100.0% GBX43.78 Million GBX0.00 GBX44.80 Million ▲ +0.0 pp
2011 100.0% GBX9.84 Million GBX0.00 GBX10.24 Million ▲ +0.0 pp
2010 100.0% GBX3.67 Million GBX0.00 GBX3.72 Million ▲ +0.0 pp
2009 100.0% GBX3.63 Million GBX0.00 GBX3.70 Million ▲ +21.9 pp
2008 78.1% GBX9.68 Million GBX2.12 Million GBX9.77 Million ▼ -21.9 pp
2007 100.0% GBX5.74 Million GBX0.00 GBX5.75 Million
pp = percentage points